| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-14 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-12 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |